DNAPrint Genomics IncOver The Counter Market:DNAG
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DNAPrint Genomics Inc | 640.0 | 0.0x | --- |
Humanigen Inc | 23.8K | 0.0x | --- |
Infinity Pharmaceuticals Inc | 90.0 | 0.0x | --- |
Adynxx Inc | 10.0 | 0.0x | --- |
Aeolus Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Rayont Inc | 25.1K | 0.0x | --- |
Company Information
DNAPrint genomics, Inc. is a development-stage pharmaceutical company. As of March 15, 2007, the Company’s pharmacogenomics products were still in development. The Company generates revenues in its consumer, forensic and genotyping services, but these services have not resulted in the generation of significant revenues. During the year ended December 31, 2006, the Company’s revenues were from the sales of its ancestry product, AncestryByDNA and genotyping services. The Company provides services that range from sequencing and genotyping to the entire process of single nucleotide polymorphisms (SNP) discovery to large industrial customers. Contract genotyping is the process of reading a genetic sequence and identifying differences in the sequence letters. This information helps researchers understand how human differences are expressed at the gene level.
Contact Information
- Headquarters
- 505 Paradise Rd Ste#281SWAMPSCOTT, MA, United States 01907
- Phone
- 941-366-3400
- Fax
- ---
Executives
- Chairman of the Board, Chief Medical Officer
- Hector Gomez
- Chief Accounting Officer
- Karen Surplus
- Chief Scientific Officer, Secretary, Director
- Tony Frudakis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $640.00 |
|---|---|
Revenue (TTM) | $1.9M |
Shares Outstanding | 644.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -326.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
